Overview

Clinical And Economic Impact Of Upfront Plerixafor In Autologous Transplantation

Status:
Completed
Trial end date:
2015-11-01
Target enrollment:
Participant gender:
Summary
This protocol will investigate the effectiveness of plerixafor in the up-front setting in avoiding a second round of mobilization and whether this translates into a clinical and economic benefit.
Phase:
Phase 2
Details
Lead Sponsor:
University of Florida
Treatments:
JM 3100
Lenograstim
Plerixafor